top of page
Writer's pictureRobin Powell

Putting the improved performance of US active managers in perspective

Updated: Oct 24





Relatively speaking, 2022 was a reasonably good year for U.S. active managers. Or was it? As Dr TIM EDWARDS from S&P Dow Jones Indices explains, about half of all actively managed large-cap U.S. equity funds still failed to beat the index. And they have some serious catching up to do to change the long-term statistics. 91% and 95% of them have underperformed the S&P 500 over ten and 20 years respectively.



For over a decade, our SPIVA® Scorecards have shown a majority of actively managed U.S. large-cap equity funds underperforming the S&P 500. According to the freshly published SPIVA U.S. Year-End 2022 Scorecard, the annual underperformance rate dropped to the slimmest of margins last year: just 51% of large-cap U.S. managers lagged the S&P 500 in 2022.



Two reasons why US active managers fared better in 2022

Two key market trends associated with active performance provide context for this figure. One, explored by Anu Ganti in an earlier blog, was a sharp relative increase in the opportunity for outperformance across a range of global equity markets. Another, specific to large-cap U.S. equities, was a reversal in the trend of strong performance of the largest stocks.


The latter point matters because one of the virtues often claimed for active management is its avoidance of perceived over-concentration in the largest stocks in the benchmark.

Accordingly, active equity funds frequently underweight the index’s largest stocks (or at least some of them); if the largest companies outperform, then active funds are more likely to lag and, compounding the issue, the weight of the largest names will have also increased — so that the active funds will, all else equal, be even more underweight. Thus, as and if the largest stocks continue to outperform, active funds might underperform in ever-increasing degrees.


This is exactly what seems to have happened between 2013 and 2021. In the summer of 2013, the largest five companies in the S&P 500 accounted for roughly 11% of the index’s weight. As Exhibit 1 shows, this concentration more than doubled to over 23% by December 2021; not coincidentally, our SPIVA U.S. Year-End 2021 Scorecard reported a one-year underperformance rate of 85% for actively managed large-cap U.S. equity funds — close to a record high for any year of the scorecard’s 20-year history.



Exhibit 1: Why conditions favoured US active managers in 2022


However, as can also be seen in Exhibit 1, concentration began to diminish in 2022. Previous market darlings, including Facebook, Amazon, Alphabet, Microsoft, Tesla and Apple, to name a few, underperformed materially. Meanwhile, as the U.S. dollar strengthened, smaller and more domestically oriented names were judged to have better prospects, while previously unfancied companies in the Materials and Energy sectors benefited from a steep rise in commodity prices. Exhibit 2 summarises the changes in fortune that swept through markets last year, comparing the annualised excess returns (versus the S&P 500) for a range of large-cap indices in two periods: December 2013 to December 2021, and over the full-year 2022.



Exhibit 2: Why conditions favoured US active managers in 2022

The longer-term record for US active managers remains very poor

Will such tailwinds for active managers continue into 2023 and beyond? It is certainly possible. But it is also worth emphasising that, even now, there is still plenty of ground for active managers to make up if they hope to change the long-term statistics; according to the year-end 2022 scorecard, 91% and 95% of all actively managed large-cap U.S. equity funds underperformed the S&P 500 over 10 years and 20 years respectively.


If an underperformance rate close to a coin-flip is taken to be a “good” year for active managers, then 2022 was a “good” year. But there were also fewer excuses for underperformance, and the long-term record suggests that the swallow of 2022 performance does not an active summer make.




© The Evidence-Based Investor MMXXIV. All rights reserved. Unauthorised use and/ or duplication of this material without express and written permission is strictly prohibited.


bottom of page